Medications that block the production of leukotrienes (zileuton / Zyflo CR) or block the actions of leukotrienes (montelukast / Singulair and zafirlukast / Accolate) have been found to provide some benefit in treating the symptoms of AERD/Samter’s Triad and in decreasing the severity of reactions to aspirin and NSAIDs.
Symbicort (budesonide and formoterol) is a combination inhaler that has an inhaled corticosteroid and a long-acting beta agonist. Long-acting beta agonist is abbreviated LABA. Symbicort is approved for the treatment of asthma for people ages 12 years and older, as well as COPD (chronic obstructive pulmonary disease). 1 It is made by AstraZeneca.
What Is Cough-Variant Asthma? Cough-variant asthma is a type of asthma in which the main symptom is a dry, non-productive cough. (A non-productive cough does not expel any mucus from the respiratory tract.) People with cough-variant asthma often have no other "classic" asthma symptoms, such as wheezing or shortness of breath.
For people with exercise-induced asthma, some activities are better than others. Activities that involve short, intermittent periods of exertion, such as volleyball, gymnastics, baseball, walking, and wrestling, are generally well tolerated by people with exercise-induced asthma.
Advair Diskus and Advair HFA Inhalers are brand names for the drug combination of fluticasone and salmeterol. Side effects are nausea, vomiting, diarrhea, headaches, and hoarseness. This drug treats asthma, bronchitis, and COPD (chronic obstructive pulmonary disease).
Breo Ellipta is a combination inhaler used once daily for the treatment of asthma in people 18 years and older whose asthma is not well controlled on an inhaled corticosteroid alone. Breo Ellipta combines two medications: fluticasone furoate, an inhaled corticosteroid, and vilanterol, a LABA.